Cannabis Science Global Health Summit Presentations

Cannabis Science Global Health Summit Presentations

The GHC summit at Harvard, is a yearly event designed to catalyze collaborations to eliminate...

  • GHC 2018

    May 2018, the Cannabis Science team participated in the 2018 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. The Global Health Catalyst (GHC) summit at Harvard, is a premier yearly event designed to catalyze high impact international collaborations to eliminate global health disparities, with main focus on cancer and related diseases. During this summit Mr. Raymond C. Dabney, the Company’s President, Chief Executive Officer (CEO), and Co-founder was named the recipient of the esteemed 2018 Harvard Global Health Catalyst (GHC) Industry Leader Award and was the keynote speaker during the Phytomedicines Session.

    The theme of the Phytomedicines Session was From Farm to Bedside: Advancing Clinical Translation of Medical Cannabis and Other Phytomedicines for Global Health. Mr. Dabney discussed the development of effective cannabinoids and the creation of the Cannabis Science Global Consortium, a research and development framework and platform to cooperate and collaborate with stakeholders worldwide. 

    Cannabis Science’s Chief Medical Officer (CMO), Dr. Allen Herman, moderated the Phytomedicines Session and also presented on the role of cannabinoids in reducing the pain therapeutic divide between developed and developing countries, and CBIS’ research and development plan.

    Pan African Ambassador for Food Security and member of the Cannabis Science Scientific Advisory Board, Dr. Brylyne Chitsunge, discussed opportunities to cultivate, extract, manufacture, package, and distribute cannabinoids in Sub-Saharan Africa along with the task of educating the rest of the continent through actions and success. The Ambassador’s main take away for the audience was the emphasis of the importance of micro-nutrition and food security within the overall approach to improve healthcare outcomes throughout all of Africa.

    GHC Europe 2018

    Cannabis Science participated in the Europe Global Health Catalyst (GHC) Summit and Summer Workshop in Germany, organized by at the University of Heidelberg and Harvard Medical School’s Global Health Catalyst. CBIS’ Scientific Advisory Board Member and Chief Executive Officer (CEO) of Elpasso Farms in South Africa, Dr. Brylyne Chitsunge, was invited to deliver a keynote address on engaging the African Diaspora, phytomedicines in global health, and closing the cancer pain divide. This two-day event held August 30th and 31st, is a pre-summit to the annual GHC Summit at Harvard Medical School in Boston, Massachusetts, and was attended by government officials, private-sector leaders, and researchers from Europe, the United States, and throughout Africa.

    As keynote speaker, Dr. Chitsunge also discussed Elpasso Farms’ and Cannabis Science’s initiatives in Africa in the areas of food security, collaborations, and economic development. The economic development initiatives presented include education, drug development, and job creation.

    Cannabis Science and Elpasso Farms have recently entered into an agreement to develop a phytomedicines initiative in South Africa. This partnership will include establishing research, development, cultivation, testing, manufacturing, and production facilities. Additionally, CBIS and Elpasso intend to establish the Pan-African Agriculture and Commerce University (PAACU), which will serve as a platform for research, drug development, education, and training throughout Africa.

    Additionally, Cannabis Science, Elpasso Farms, and Harvard Medical School’s GHC recently announced the signing of a historic collaboration agreement to develop initiatives throughout

    GHC 2017

    April 2017, the Cannabis Science team participated in the 2017 Global Health Catalyst Summit held at Harvard Medical School in Boston, MA. Mr. Dabney was the keynote speaker and panelist for a special session on “Cannabis Science Versus Cancer and Other Malignancies”.

    Mr. Dabney discussed how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science’s vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research. 

    Additionally, Mr. Dabney presented summit participants with an overview of the company's drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). Dr. Allen Herman, Chief Medical Officer (CMO) of CBIS, Inc. Co-Chaired this session and participated in the discussion on the epidemiology of cancer and the utilization of opioids in Africa, which reflects the pain divide. Mr. Dabney and Dr. Herman lead CBIS’ collaboration with DFCI. 

  • Category
  • Created
    Thursday, 24 January 2019
  • Group admin
    Raymond C. Dabney

American States University


Sac Court Capture

Case No. 2:17-CV-02271-KJM-JDP

Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB

Click here to review the Report:

Frontiers Capture

 Harvard GHC Award RCD 2018

It's CERTAINLY working and gaining momentum! ASU is targeting $20 MILLION from 1 Million people for Cannabis Science Research to Keep Killing CANCERS and progress ASU/CSi-EDP International Expansions. Exactly why we Won the 2018 HARVARD Industry Leader Award. Lets Keep on Killing Cancers!

CLICK HERE to Join Now!

Cannabis Science $CSi-EDP Crypto-ECO-System

Build your Dreams! …
Your Worldwide $CSi-EDP Crypto-ECO-System

VIP Online Bank


Become an iCannabinoid Ambassador


Observational Studies


Activity Stream

Raymond C. Dabney shared a photo. 14 hours 29 minutes ago

ENDO & CBIS Shareholder Updates

Thermic Science International Corporation (ENDO)

Cannabis Science Inc. 

Raymond C. Dabney, President 
Robert Kane, Director & CFO 

TOP Priorities and Updates:

Today, 4th of July 2022

Happy Fourth of July Guys!
BBQ's, Picnics, Family, Friends, Fun, Relax! nice.
Of course, it's raining in Vancouver today! Lol.

Talk about Cleaning HOUSE !!!

It's all about this FINAL PUSH !!!

Fourth and GOAL. What will happen?

It’s been a Wild ride for sure.
I really hope this court thing is over!

This is our Money and our Shares we are talking about.

We are all Shareholders!
This is our SUCCESS we are Invested.

We are the one's to Protect it.

This is for OUR Money and our Shares!


This is for OUR Company, our Success.

This CAN bring us back to our normal position of Strength.

This CAN get all our ASSETS back, our MONEY back.

This CAN change things instantly.

This CAN bring our shares trading FASTER as they were and better.

This CAN give us all our $$$ Value back, instantly.


If you can send $$$ then PLEASE DO SO now!

We need you to send now!

*** Please remember July 8, 2022 is the date so time is not on our side.

Thanks Guys!

Yep, we are nervous for all of us, we KNOW what this is worth we built it all.
We went to HARVARD and KILLED CANCER, never mind everywhere else.

We did this ALL for Cannabis Science GROWTH VALUE SUCCESS.
We all know this, now we must FIGHT for it.
Well, we are fighting, I hope you are too!

Eyes on the Prize.
I'm trying to get Everyone to focus:

How much is that worth?
Never mind the rest.

We already WON !!!

*** Completing TV Production phases now.

Phase 1 - July 2022 Completion.
Episode 1, The Road to HARVARD

Phase 2 - August 2022 Completion
Episode 2, The Road to 1 Million STRONG, Initial Celebrity Introductions

Phase 3 - September 2022
Episode 3, ASU/CSi-EDP
Worldwide On-Location Introductions

1 Million STRONG TV Variety Show
The Road to HARVARD Cancer Killing Success
The Road to 1 Million STRONG Killing Cancers
ASU/CSi-EDP Worldwide Digital Immersion 

Celebrities raising $20 Million 
to KEEP killing CANCERS 

We Win.We Won.
Game ON!

That's why HARVARD gave us the AWARD. Period, this will be a GOOD Episode too!

Any more questions?  for ALL our Products and Services!
ASU/CSi-EDP Partnerships! 
Send me an email and we will respond accordingly.

Thanks Guys!
Thanks for keep sending the $$$ to KEEP Pushing!
JULY 8, 2022

*** According to these emails I'm seeing, It's already getting HOT in here! July 8, 2022.
Talk soon!

Thanks again!

Lets try this email:


*** All CBIS shares are VERIFIED & Accounted via 
SEC confirmation. All Shares are Company and Transfer Agent verified.  

Transfer Agent holding your Cannabis Science Shares:


We appreciate your Patience. Website updates are underway according to Priority. All our Shares, Products, Services, Initiatives, and Companies. 

Stay tuned! Check back soon for updates everywhere!




Sorry, we currently have no events.
View All Events